Alimera Sciences, Inc. (ALIM)
NASDAQ
Market Cap
$289.18M
Sector
Healthcare
Industry
Drug Manufacturers—Specialty & Generic
Rank in Sector
101 of 809
Rank in Industry
4 of 53
Largest Insider Buys in Sector
ALIM Stock Price History Chart
ALIM Stock Performance
About Alimera Sciences, Inc.
Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.
Insider Activity of Alimera Sciences, Inc.
Over the last 12 months, insiders at Alimera Sciences, Inc. have bought $1.96M and sold $1.96M worth of Alimera Sciences, Inc. stock.
On average, over the past 5 years, insiders at Alimera Sciences, Inc. have bought $956,147 and sold $862,127 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Caligan Partners LP (10 percent owner) — $3.93M.
The last purchase of 579,000 shares for transaction amount of $1.96M was made by Caligan Partners LP (10 percent owner) on 2023‑09‑14.
List of Insider Buy and Sell Transactions, Alimera Sciences, Inc.
| 2023-09-14 | Sale | Caligan Partners LP | 10 percent owner | 579,000 1.1046% | $3.39 | $1.96M | +2.95% | |
| 2023-09-14 | Caligan Partners LP | 10 percent owner | 579,000 1.1046% | $3.39 | $1.96M | +2.95% | ||
| 2023-05-17 | Morgan Adam | 1.4M 16.4515% | $1.70 | $2.38M | +65.53% | |||
| 2023-03-24 | Sale | Palo Alto Investors LP | 10 percent owner | 200,919 3.3223% | $1.56 | $314,117 | +143.52% | |
| 2022-02-08 | Sale | MORGAN STANLEY | 10 percent owner | 250,000 3.5762% | $4.55 | $1.14M | +16.70% | |
| 2021-12-15 | EISWIRTH RICHARD S JR | President and CEO | 484 0.0072% | $4.50 | $2,177 | +15.18% | ||
| 2021-12-03 | EISWIRTH RICHARD S JR | President and CEO | 5,000 0.0785% | $4.80 | $23,981 | +14.69% | ||
| 2021-12-02 | EISWIRTH RICHARD S JR | President and CEO | 5,000 0.0756% | $4.89 | $24,428 | +8.37% | ||
| 2021-11-05 | EISWIRTH RICHARD S JR | President and CEO | 1,400 0.0205% | $5.50 | $7,700 | -5.96% | ||
| 2021-11-04 | EISWIRTH RICHARD S JR | President and CEO | 10,086 0.1498% | $4.41 | $44,446 | +19.11% | ||
| 2021-11-03 | EISWIRTH RICHARD S JR | President and CEO | 28,005 0.426% | $4.45 | $124,745 | +20.72% | ||
| 2021-11-03 | Holland David | Chief Marketing Officer & SVP | 5,000 0.0696% | $4.08 | $20,392 | +20.72% | ||
| 2021-11-03 | Jones John Philip | Chief Financial Officer | 5,000 0.0697% | $4.08 | $20,399 | +20.72% | ||
| 2021-11-03 | Largent James R | director | 10,000 0.1472% | $4.31 | $43,090 | +20.72% | ||
| 2021-04-08 | Sale | Ashman Philip | Chief Operating Officer & SVP | 45 0.0006% | $9.62 | $433 | -41.14% | |
| 2020-11-04 | Ashman Philip | Chief Operating Officer & SVP | 1,316 0.0278% | $4.50 | $5,922 | +102.41% | ||
| 2020-11-02 | EISWIRTH RICHARD S JR | President and CEO | 2,500 0.0483% | $4.15 | $10,377 | +100.38% | ||
| 2020-08-20 | Sale | Myers C. Daniel | director | 5,000 0.0978% | $6.73 | $33,650 | +17.75% | |
| 2019-12-10 | Jones John Philip | Chief Financial Officer | 1,000 0.0161% | $9.29 | $9,294 | -40.32% | ||
| 2019-11-21 | Snisarenko John | director | 10,000 0.1684% | $4.95 | $49,500 | +18.89% |
Insider Historical Profitability
<0.0001%
| Caligan Partners LP | 10 percent owner | 16835154 32.1179% | $5.52 | 1 | 1 | |
| ARMISTICE CAPITAL, LLC | 10 percent owner | 6936000 13.2324% | $5.52 | 3 | 0 | <0.0001% |
| Brooks Mark J | 4863094 9.2777% | $5.52 | 1 | 0 | <0.0001% | |
| Flynn James E | 10 percent owner | 4760408 9.0818% | $5.52 | 19 | 0 | <0.0001% |
| BAVP, L.P. | 10 percent owner | 3998718 7.6287% | $5.52 | 1 | 40 | <0.0001% |
| Hove Anders D | 3949070 7.534% | $5.52 | 1 | 0 | <0.0001% | |
| VENROCK ASSOCIATES IV L P | 10 percent owner | 3949070 7.534% | $5.52 | 1 | 0 | <0.0001% |
| Domain Partners VI, L.P. | 10 percent owner | 3590931 6.8507% | $5.52 | 1 | 10 | <0.0001% |
| Lee Patrick | 10 percent owner | 3013793 5.7497% | $5.52 | 0 | 3 | |
| Intersouth Associates VI, LLC | 10 percent owner | 2053381 3.9174% | $5.52 | 1 | 0 | <0.0001% |
| Morgan Adam | 1659654 3.1663% | $5.52 | 1 | 0 | +65.53% | |
| Intersouth Associates V, LLC | 10 percent owner | 1605743 3.0634% | $5.52 | 1 | 0 | <0.0001% |
| Intersouth Associates VII, LLC | 10 percent owner | 1144766 2.184% | $5.52 | 1 | 0 | <0.0001% |
| MORGAN STANLEY | 10 percent owner | 557551 1.0637% | $5.52 | 0 | 1 | |
| Green Kenneth | SVP & Chief Scientific Officer | 170634 0.3255% | $5.52 | 0 | 7 | |
| EISWIRTH RICHARD S JR | President and CEO | 110518 0.2108% | $5.52 | 13 | 9 | +17.51% |
| Caballa Susan | See Remarks | 77432 0.1477% | $5.52 | 2 | 1 | <0.0001% |
| Roberts Calvin W. | director | 65820 0.1256% | $5.52 | 5 | 1 | <0.0001% |
| Polaris Venture Management Co IV LLC | 10 percent owner | 57586 0.1099% | $5.52 | 1 | 5 | <0.0001% |
| TREU JESSE I | 10 percent owner | 40790 0.0778% | $5.52 | 1 | 1 | <0.0001% |
| BLAIR JAMES C | 10 percent owner | 40790 0.0778% | $5.52 | 1 | 1 | <0.0001% |
| DOVEY BRIAN H | 10 percent owner | 40790 0.0778% | $5.52 | 1 | 1 | <0.0001% |
| VITULLO NICOLE | 10 percent owner | 40790 0.0778% | $5.52 | 1 | 1 | <0.0001% |
| SCHOEMAKER KATHLEEN K | 10 percent owner | 40790 0.0778% | $5.52 | 1 | 1 | <0.0001% |
| DP VI Associates, L.P. | 10 percent owner | 34907 0.0666% | $5.52 | 0 | 11 | |
| Holland David | Chief Marketing Officer & SVP | 31130 0.0594% | $5.52 | 2 | 17 | <0.0001% |
| Jones John Philip | Chief Financial Officer | 24965 0.0476% | $5.52 | 3 | 0 | +2.06% |
| Ashman Philip | Chief Operating Officer & SVP | 19379 0.037% | $5.52 | 1 | 5 | +102.41% |
| Largent James R | director | 13000 0.0248% | $5.52 | 2 | 0 | +15.4% |
| BRADLEY GLEN | director | 10047 0.0192% | $5.52 | 1 | 0 | +114.89% |
| Snisarenko John | director | 10000 0.0191% | $5.52 | 1 | 0 | +18.89% |
| Pizzo Peter J. III | director | 7500 0.0143% | $5.52 | 2 | 0 | +47.44% |
| Myers C. Daniel | director | 5578 0.0106% | $5.52 | 0 | 24 | |
| Palo Alto Investors LP | 10 percent owner | 0 0% | $5.52 | 0 | 1 |
Institutional Investor Ownership
Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
| Caligan Partners LP | $65.66M | 32.14 | 16.84M | 0% | +$0 | 17.36 | |
| Velan Capital | $53.07M | 25.98 | 13.61M | 0% | +$0 | 28.88 | |
| Stonepine Capital Management Llc | $15.8M | 7.73 | 4.05M | +1.29% | +$201,290.70 | 12.75 | |
| Boothbay Fund Management LLC | $12.47M | 6.11 | 3.2M | 0% | +$0 | 0.42 | |
| Altium Capital Management Lp | $9.95M | 4.87 | 2.55M | -4.13% | -$429,000.00 | 4.62 | |
| Clearline Capital LP | $8.13M | 3.98 | 2.09M | -3.87% | -$327,022.80 | 0.8 | |
| Aigh Capital Management Llc | $5.93M | 2.9 | 1.52M | -31.7% | -$2.75M | 3.52 | |
| The Vanguard Group | $4.08M | 2 | 1.05M | +61.1% | +$1.55M | <0.0001 | |
| Morgan Stanley | $1.96M | 0.96 | 501,738 | -45.24% | -$1.62M | <0.0001 | |
| BlackRock | $1.88M | 0.92 | 483,294 | +8.89% | +$153,874.53 | <0.0001 | |
| Geode Capital Management | $1.48M | 0.72 | 378,237 | +13.94% | +$180,478.42 | <0.0001 | |
| Ancora Advisors Llc | $915,018.00 | 0.45 | 234,620 | New | +$915,018.00 | 0.02 | |
| Bank of Montreal | $757,910.00 | 0.36 | 188,067 | +51.3% | +$256,993.10 | <0.0001 | |
| Renaissance Technologies | $682,000.00 | 0.33 | 174,794 | +10.08% | +$62,427.77 | <0.01 | |
| Bridgeway Capital Management | $542,490.00 | 0.27 | 139,100 | +595.5% | +$464,490.00 | 0.01 | |
| State Street | $518,762.00 | 0.25 | 133,016 | New | +$518,762.00 | <0.0001 | |
| Millennium Management LLC | $492,020.00 | 0.24 | 126,159 | +288.65% | +$365,422.13 | <0.0001 | |
| Susquehanna International Group | $417,694.00 | 0.2 | 107,101 | -3.17% | -$13,685.10 | <0.0001 | |
| Marshall Wace | $332,674.00 | 0.16 | 85,301 | New | +$332,674.00 | <0.0001 | |
| Northern Trust | $286,330.00 | 0.14 | 73,418 | +419.52% | +$231,215.24 | <0.0001 | |
| Goldman Sachs | $279,856.00 | 0.14 | 71,758 | New | +$279,856.00 | <0.0001 | |
| Citigroup | $239,538.00 | 0.12 | 61,420 | +99.36% | +$119,386.80 | <0.0001 | |
| Qube Research & Technologies | $182,044.00 | 0.09 | 46,678 | New | +$182,044.00 | <0.0001 | |
| Hillsdale Investment Management Inc. | $169,260.00 | 0.08 | 43,400 | New | +$169,260.00 | 0.01 | |
| Citadel Advisors LLC | $112,597.00 | 0.06 | 28,871 | +45.27% | +$35,088.33 | <0.0001 | |
| Jefferies Financial Group | $101,790.00 | 0.05 | 26,100 | +102.33% | +$51,480.00 | <0.01 | |
| Hrt Financial Llc | $99,000.00 | 0.05 | 25,586 | New | +$99,000.00 | <0.01 | |
| Bank of America | $91,744.00 | 0.05 | 23,524 | +13.12% | +$10,639.25 | <0.0001 | |
| JPMorgan Chase | $86,327.00 | 0.04 | 22,135 | +36,186.89% | +$86,089.10 | <0.0001 | |
| Fifth Lane Capital Lp | $82,828.00 | 0.04 | 21,238 | New | +$82,828.00 | 0.02 | |
| Balyasny Asset Management Llc | $40,260.00 | 0.02 | 10,323 | -74.21% | -$115,865.96 | <0.0001 | |
| Advisor Group Holdings Inc | $15,853.00 | 0.01 | 4,065 | 0% | +$0 | <0.0001 | |
| Tower Research Capital | $3,682.00 | <0.01 | 944 | +214.67% | +$2,511.87 | <0.0001 | |
| Macquarie Group | $2,000.00 | <0.01 | 523 | New | +$2,000.00 | <0.0001 | |
| Wells Fargo | $1,119.00 | <0.01 | 287 | +1.77% | +$19.50 | <0.0001 | |
| Steward Partners Investment Advisory LLC | $2,597.00 | <0.01 | 666 | New | +$2,597.00 | <0.0001 | |
| Comerica | $55.00 | <0.01 | 14 | 0% | +$0 | <0.0001 | |
| Royal Bank of Canada | $0 | <0.01 | 22 | 0% | +$0 | <0.0001 |